Molecular targets for treatment of kidney fibrosis
PY Chuang, MC Menon, JC He - Journal of molecular medicine, 2013 - Springer
Renal fibrosis is the culmination of processes driven by signaling pathways involving
transforming growth factor-β family of cytokines, connective-tissue growth factor, nuclear …
transforming growth factor-β family of cytokines, connective-tissue growth factor, nuclear …
[HTML][HTML] Targeting the Wnt/β-catenin signaling pathway as a potential therapeutic strategy in renal tubulointerstitial fibrosis
SS Li, Q Sun, MR Hua, P Suo, JR Chen… - Frontiers in …, 2021 - frontiersin.org
The Wnt/β-catenin signaling pathway plays important roles in embryonic development and
tissue homeostasis. Wnt signaling is induced, and β-catenin is activated, associated with the …
tissue homeostasis. Wnt signaling is induced, and β-catenin is activated, associated with the …
Cellular and molecular mechanisms of kidney fibrosis
Renal fibrosis is the final pathological process common to any ongoing, chronic kidney
injury or maladaptive repair. It is considered as the underlying pathological process of …
injury or maladaptive repair. It is considered as the underlying pathological process of …
Wnt/β-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease
I Hwang, E Seo, H Ha - Archives of pharmacal research, 2009 - Springer
Fibrosis of epithelial parenchymal organs and end-stage organ failure, the final common
pathway of many progressive chronic diseases including chronic kidney disease, continue …
pathway of many progressive chronic diseases including chronic kidney disease, continue …
[HTML][HTML] Kidney fibrosis: from mechanisms to therapeutic medicines
R Huang, P Fu, L Ma - Signal Transduction and Targeted Therapy, 2023 - nature.com
Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney
fibrosis, characterized by excessive extracellular matrix deposition leading to scarring, is a …
fibrosis, characterized by excessive extracellular matrix deposition leading to scarring, is a …
[HTML][HTML] Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis
H Yan, J Xu, Z Xu, B Yang, P Luo, Q He - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Renal fibrosis is a failed wound-healing process of the kidney tissue after chronic, sustained
injury, which is a common pathway and pathological marker of virtually every type of chronic …
injury, which is a common pathway and pathological marker of virtually every type of chronic …
Mechanisms of kidney fibrosis and routes towards therapy
N Yamashita, R Kramann - Trends in Endocrinology & Metabolism, 2024 - cell.com
Kidney fibrosis is the final common pathway of virtually all chronic kidney diseases (CKDs)
and is therefore considered to be a promising therapeutic target for these conditions …
and is therefore considered to be a promising therapeutic target for these conditions …
Novel targets for therapy of renal fibrosis
N Prakoura, J Hadchouel… - … of Histochemistry & …, 2019 - journals.sagepub.com
Renal fibrosis is an important component of chronic kidney disease, an incurable pathology
with increasing prevalence worldwide. With a lack of available therapeutic options, end …
with increasing prevalence worldwide. With a lack of available therapeutic options, end …
Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis
H Okada, R Kalluri - Current molecular medicine, 2005 - ingentaconnect.com
Renal fibrosis is a common consequence and often a central feature of all the progressive
renal diseases that lead to end-stage renal failure. In comparison to wound healing, during …
renal diseases that lead to end-stage renal failure. In comparison to wound healing, during …
New therapeutic targets in chronic kidney disease progression and renal fibrosis
S Rayego-Mateos, JM Valdivielso - Expert Opinion on Therapeutic …, 2020 - Taylor & Francis
Introduction The current therapeutic armamentarium to prevent chronic kidney disease
(CKD) progression is limited to the control of blood pressure and in diabetic patients, the …
(CKD) progression is limited to the control of blood pressure and in diabetic patients, the …